Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Depreciation & Amortization (CF) (2016 - 2025)

Anaptysbio (ANAB) has disclosed Depreciation & Amortization (CF) for 10 consecutive years, with $131000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 9.66% year-over-year to $131000.0, compared with a TTM value of $559000.0 through Dec 2025, down 7.76%, and an annual FY2025 reading of $559000.0, down 7.76% over the prior year.
  • Depreciation & Amortization (CF) was $131000.0 for Q4 2025 at Anaptysbio, down from $140000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $184000.0 in Q4 2022 and bottomed at $125000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $155550.0, with a median of $161000.0 recorded in 2021.
  • The sharpest move saw Depreciation & Amortization (CF) increased 29.6% in 2022, then decreased 12.12% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $165000.0 in 2021, then increased by 11.52% to $184000.0 in 2022, then dropped by 10.33% to $165000.0 in 2023, then fell by 12.12% to $145000.0 in 2024, then fell by 9.66% to $131000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for ANAB at $131000.0 in Q4 2025, $140000.0 in Q3 2025, and $142000.0 in Q2 2025.